The American College of Cardiology (ACC), the American Heart Association, and nine other leading medical associations today issued an updated guideline for the treatment of dyslipidemia and abnormal levels of one or more types of lipids or lipoproteins in the blood, including cholesterol and triglycerides. It is estimated that 1 in 4 adults in the US has high levels of low-density lipoprotein cholesterol (LDL-C), which increase the risk of heart attack and stroke. The guideline summarizes evidence-based recommendations for the treatment of dyslipidemias in one document and provides a comprehensive "one-stop shop" for the best assessment and treatment of various blood fats to effectively lower a person's risk of developing atherosclerotic cardiovascular disease (ASCVD). ASCVD is caused by the buildup of fatty deposits in the arteries and is the leading cause of death worldwide. The document was jointly published today in JACC, the flagship journal of the American College…